Last reviewed · How we verify

NCT06056219

Rhythmic-Based Training with Immersive Mirror Visual Feedback for Neuro-Rehabilitation

Completed NA Last updated 16 December 2024
What this trial tests

NA trial testing Mirror therapy in Stroke in 36 participants. Completed in 24 October 2024.

Timeline
3 October 2023
Primary endpoint
15 October 2024
24 October 2024

Quick facts

Lead sponsorNational Cheng-Kung University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date3 October 2023
Primary completion15 October 2024
Estimated completion24 October 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Cheng-Kung University Hospital

Who can join

18 and older, any sex, with Stroke or Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the proposed study, the investigators assumed that rhythmic-based training with immersive mirror visual feedback will provide a better treatment effects than traditional mirror therapy for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either rhythmic-based training with immersive mirror visual feedback, or mirror therapy on the upper extremity function and brain activity of the stroke patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mirror therapy

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06056219.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing